Correlations among prostatic biopsy results, transrectal ultrasound findings and PSA levels in diagnosing prostate adenocarcinoma

European Journal of Ultrasound

Volumn 12, Issue 2, 2000, Pages 103-113

  Kokeny G P ^a   Cerri, G G ^a   De Oliveira Cerri, L M ^a   De Barros, N ^a,b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

Prostate adenocarcinoma; Prostate biopsy; PSA levels; TRUS

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DIAGNOSTIC ACCURACY; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE BIOPSY; TRANSRECTAL ULTRASONOGRAPHY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CHI-SQUARE DISTRIBUTION; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS;

EID: 0034548889     PISSN: 09298266     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0929-8266(00)00100-2     Document Type: Article

References (50)

1. Biopsy of the prostate guided by transrectal ultrasonography: Early experience in a teaching community hospital
2. The diagnosis and treatment of prostate cancer
3. Three-dimensional computer-simulated prostate models: Lateral prostate biopsies increase the detection rate of prostate cancer
4. Advantage of systematic random ultrasound-guided biopsies, measurement of serum prostate-specific antigen level and determination of prostate volume in the early diagnosis of prostate cancer
5. Comparison of digital rectal examination and serum prostate-specific antigen in the early detection of prostate cancer: Results of a multicenter clinical trial of 6630 men
6. Prostate cancer: Current and evolving strategies
7. Screening for prostate cancer. Role of ultrasonography
8. Early detection and screening for prostatic cancer
9. Prevalence and pathological extent of prostate cancer in men with prostate-specific antigen levels of 2.9 to 4.0 ng/ml
10. Transrectal sonography for serial evaluation of prostatic malignancy
11. Prostatic cancer diagnosis with ultrasonically guided prostatic biopsy: Results in 226 cases
12. Value of random US-guided transrectal prostate biopsy
13. Three-dimensional computer reconstruction of prostate cancer from radical prostatectomy specimens: Evaluation of the model by core biopsy simulation
14. Prostate-specific antigen detected prostate cancer: Pathological characteristics of ultrasound visible versus ultrasound invisible tumors
15. Diagnosis and markers in prostate cancer
16. Accuracy of digital rectal examination and transrectal ultrasonography in localizing prostate cancer
17. Transrectal ultrasound in early detection of clinical stage A prostate cancer
18. The ultrasound appearances of prostatic cancer with histological correlation
19. The current status of transrectal ultrasonography in the diagnosis and management of prostatic cancer
20. Prostate ultrasonography
21. Random systemic versus directed ultrasound guided transrectal core biopsies of the prostate
22. Significance of the palpable prostatic nodule
23. The present status of radical prostatectomy for Stage A and B prostatic cancer
24. Prostate biopsy indices: Toward efficient use of transrectal ultrasound
25. Serial prostatic biopsies in men with persistently elevated serum prostate-specific antigen values
26. Use of transrectal ultrasound and prostate-specific antigen in diagnosis of prostatic intraepithelial neoplasia
27. Hypoechoic lesions of the prostate: Clinical relevance of tumor size, digital rectal examination, and prostate-specific antigen
28. Transrectal ultrasound-guided biopsy of the prostate: What you see is not what you get
29. Determination of prostate volume with transrectal US for cancer screening
30. Role of transrectal ultrasound and prostate biopsy
31. Detection of clinically occult prostate cancer
32. Clinical and pathologic tumor characteristics of prostate cancer as a function of the number of biopsy cores: A retrospective study
33. The sextant protocol for ultrasound-guided core biopsies of the prostate underestimates the presence of cancer
34. Prostate-specific antigen and screening for prostate cancer: Much ado about something?
35. The optimal systematic prostate biopsy scheme should include 8 rather than 6 biopsies: Results of a prospective clinical trial
36. Value of transrectal prostatic echography, prostate-specific antigen and rectal examination in the diagnosis of prostate cancer. Relationship with the result of prostatic biopsies
37. Transrectal ultrasound
38. Implications of small, peripheral hypoechoic lesions in endorectal US of the prostate
39. Diagnostic yield of repeated transrectal ultrasound-guided biopsies stratified by specific histopathologic diagnoses and prostate-specific antigen levels
40. Early detection of prostate cancer
41. Early detection of prostate cancer in men with prostatism and intermediate prostate-specific antigen levels
42. Stage A adenocarcinoma of the prostate: Transrectal US and sonographic-pathologic correlation
43. Pathologic basis of the sonographic appearance of the normal and malignant prostate
44. The appearance of prostate cancer on transrectal ultrasonography: Correlation of imaging and pathological examinations
45. Is transrectal ultrasonography needed to rule out prostatic cancer with normal findings at digital rectal examination and normal serum prostate-specific antigen?
46. Transrectal ultrasound screening for prostatic adenocarcinoma with histopathologic correlation
47. Sensitivity and specificity of sextant biopsies in detection of prostate cancer: Preliminary report
48. Systematic prostatic biopsies in 100 men with no suspicion of cancer on digital rectal examination
49. Correlation between prostate-specific antigen and prostate volume, evaluated by transrectal ultrasonography: Usefulness in diagnosis of prostate cancer
50. Effects of rectal examination, prostatic massage, ultrasonography and needle biopsy on serum prostate-specific antigen levels